GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $51,000 | -3.8% | 23,450 | 0.0% | 0.00% | – |
| Q4 2020 | $53,000 | -15.9% | 23,450 | 0.0% | 0.00% | – |
| Q3 2020 | $63,000 | -12.5% | 23,450 | 0.0% | 0.00% | – |
| Q2 2020 | $72,000 | +56.5% | 23,450 | 0.0% | 0.00% | – |
| Q1 2020 | $46,000 | -31.3% | 23,450 | 0.0% | 0.00% | – |
| Q4 2019 | $67,000 | -22.1% | 23,450 | 0.0% | 0.00% | – |
| Q3 2019 | $86,000 | -11.3% | 23,450 | 0.0% | 0.00% | – |
| Q2 2019 | $97,000 | -19.2% | 23,450 | 0.0% | 0.00% | – |
| Q1 2019 | $120,000 | +50.0% | 23,450 | 0.0% | 0.00% | – |
| Q4 2018 | $80,000 | -43.3% | 23,450 | 0.0% | 0.00% | – |
| Q3 2018 | $141,000 | -5.4% | 23,450 | 0.0% | 0.00% | – |
| Q2 2018 | $149,000 | +34.2% | 23,450 | 0.0% | 0.00% | – |
| Q1 2018 | $111,000 | +42.3% | 23,450 | 0.0% | 0.00% | – |
| Q4 2017 | $78,000 | +56.0% | 23,450 | 0.0% | 0.00% | – |
| Q3 2017 | $50,000 | -13.8% | 23,450 | 0.0% | 0.00% | – |
| Q2 2017 | $58,000 | +7.4% | 23,450 | 0.0% | 0.00% | – |
| Q1 2017 | $54,000 | +134.8% | 23,450 | 0.0% | 0.00% | – |
| Q4 2016 | $23,000 | -14.8% | 23,450 | 0.0% | 0.00% | – |
| Q3 2016 | $27,000 | -22.9% | 23,450 | 0.0% | 0.00% | – |
| Q2 2016 | $35,000 | +2.9% | 23,450 | 0.0% | 0.00% | – |
| Q1 2016 | $34,000 | -10.5% | 23,450 | 0.0% | 0.00% | – |
| Q4 2015 | $38,000 | -30.9% | 23,450 | 0.0% | 0.00% | – |
| Q3 2015 | $55,000 | -14.1% | 23,450 | 0.0% | 0.00% | – |
| Q2 2015 | $64,000 | -23.8% | 23,450 | 0.0% | 0.00% | – |
| Q1 2015 | $84,000 | 0.0% | 23,450 | 0.0% | 0.00% | – |
| Q4 2014 | $84,000 | -28.8% | 23,450 | 0.0% | 0.00% | – |
| Q3 2014 | $118,000 | -63.6% | 23,450 | 0.0% | 0.00% | – |
| Q2 2014 | $324,000 | +14.9% | 23,450 | 0.0% | 0.00% | – |
| Q1 2014 | $282,000 | +48.4% | 23,450 | 0.0% | 0.00% | – |
| Q4 2013 | $190,000 | -18.8% | 23,450 | 0.0% | 0.00% | – |
| Q3 2013 | $234,000 | +134.0% | 23,450 | 0.0% | 0.00% | – |
| Q2 2013 | $100,000 | – | 23,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |